Mondana Cook joins PBD Biotech to bring human TB diagnostic to market
New Chief Operating Officer brings experience of tuberculosis vaccine and precision medicine to progress Actiphage diagnosis to meet the global TB challenge.
CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities
State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for Organ-on-a-Chip research services
Summer update – Guardtech continue to shine as brilliant builds mount up
The Group have enjoyed a super-busy start to 2022 – and there’s still a lot more to come
Sensors in Medicine 2022 Program - engage with Captum Capital
Clinical diagnostic medicine and healthcare monitoring are arguably the most important applications of biosensor technology. The Covid-19 pandemic has demonstrated both the need for advanced diagnostic sensors as well as the capability of research groups around the world to respond rapidly to this unprecedented need. The 10th Annual Sensors in Medicine 2022 conference will highlight the newest…
Have your say - what biotech employees really want
Singular Talent is conducting a research survey and would like your help.
Diversity – the human factor
A member of Team Consulting says: in June 2022, UK’s Sheffield Hallam University announced it was closing its English Literature degree course. A debate followed in the press over the value of humanities degrees. I was glad to see many people echoing the thoughts I’ve had about the value of an English degree. It made me, in turn, reflect on the value of diversity in a consultancy like Team…
FUJIFILM Irvine Scientific Opens New Armstrong R&D Cell Culture Center of Excellence
SANTA ANA, California, FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, has announced the completion of its Armstrong Cell Culture Center of Excellence. More than doubling the R&D facility’s footprint, the new state-of-the-art center enables the Company to…
Mutation pathway to bowel cancer discovered
New research has found that inherited mutations in the MUTYH gene, which repairs oxidative DNA damage, are linked to an increased mutation rate in healthy tissues and a higher risk of developing bowel cancer.
AstraZeneca to fund a further 55 PhD studentships with University of Cambridge
The University of Cambridge has formed a new agreement with AstraZeneca for the global biopharmaceuticals company to fund 55 additional PhD studentships over the next five years, starting in October 2022. Over the last 20 years, AstraZeneca has funded more than 100 PhD students from the University as part of a longstanding partnership between the two institutions.
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring
Hercules, Calif - Bio-Rad Laboratories, Inc, a global leader in life science research and clinical diagnostic products, extends its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to brentuximab vedotin (Adcetris), secukinumab (Cosentyx), and the secukinumab–interleukin 17A (IL-17A) drug-target complex. These sequence-defined antibodies are…
Tailor Bio boosted by Innovate UK award
Tailor Bio, a Techbio startup based in Cambridge UK has been successful in leading a £650k grant collaboration for the Innovate UK Biomedical Catalyst Award.
AI-powered drug discovery company Healx opens new labs at Chesterford Research Park
Chesterford Research Park welcomes Healx to the Park’s prestigious Science Village.
Centauri Therapeutics strengthens senior leadership team with three key appointments
Centauri Therapeutics Limited (Centauri), an immunotherapy company focused on the treatment of infectious diseases, today announced three senior appointments: Dr Jennifer Schneider as Chief Executive Officer (CEO), Dr Helen Bright as Vice President (VP) of Research & Development (R&D), and Professor David Roblin FRCP FMedSci as Chair of the Board of Directors.
Anthias Consulting courses at heart of analytical chemistry training in Africa
In June 2022, Anthias Consulting's training course materials were used to deliver a week-long practical based LC-MS workshop at the Kwame Nkrumah University of Science and Technology (KNUST) in Ghana.
Breakfast or Hotel Bar?
WaveFX says: So, after two years adapting to virtual and hybrid events from the studio and breakfast bar we’re happily back on the road. This week the WaveFX stream team produced and filmed webcasts and live events from conference hotels and venues across the UK, Sweden and Greece.
5 things every electrical medical device start-up should know
You’ve got a great idea for an electrical medical device, whether that’s a connected injector, point of care diagnostics device, a wearable device, or another innovative, life-changing device concept. You’ve identified a market for it, gained access to sector insights, you’ve tested the principles and are getting good results. All you need now is to engineer it into a real medical device product…
First genetic map of one of humans oldest parasites
The largest genomic analysis of the whipworm Trichuris trichiura has been published, giving the most in-depth evolutionary insight about this human parasite to date.
What you need to know when hiring workers from abroad
Has recruitment for your business got you thinking about hiring workers from overseas? There are a few things you need to know to ensure you remain compliant with employment law. We explore this topic further in our latest blog.
Hospital’s green bus service is just the ticket for patients and planet
Cambridge University Hospitals (CUH) has launched an environmentally friendly patient courtesy bus service, thanks to a team effort by ACT and a well-known patient governor.
Charity’s first Newmarket Race Day raises more than £40,000 to fund a psychologist for children with brain tumours
A children’s charity’s first ever race day at Newmarket Racecourse has raised more than £40,000 to fund a psychologist for families faced with a brain tumour.
Prologis starts construction on speculative life science development at Cambridge Biomedical Campus
Work has started on the first wholly speculative development of new multi-let laboratory and office space at Cambridge Biomedical Campus, which is specifically targeting a range of growing biotech and life science businesses.
AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening its haematological cancer pipeline
AstraZeneca announces an agreement to acquire TeneoTwo, Inc., including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluation in relapsed and refractory B-cell non-Hodgkin lymphoma1.
£900m investment to create one of Europe’s largest life sciences hubs in Stevenage
Stevenage Bioscience Catalyst - developer named for campus expansion.
Ubiquigent appoints Professor Helen Walden and Professor John Davis to Scientific Advisory Board
Experts in structural biology and drug development will help exploit the deubiquitylase (DUB) enzyme family as new drug targets
Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss
Mogrify Limited, a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, and Astellas Pharma Inc., a leader in regenerative medicine, today announced that they have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.